HAUPPAUGE – November 10, 2026 -- Long Island patients with retinal disease can now see a new fellowship-trained retina specialist at SightMD's Smithtown and Bay Shore offices. Eva Raparia, MD, a board-certified ophthalmologist, is accepting patients at both locations.
She treats macular degeneration, diabetic retinopathy and vein occlusions
Dr. Raparia focuses on the medical management of retinal diseases. These include age-related macular degeneration, diabetic retinopathy, retinal vein occlusions and other complex retinal conditions.
She also performs in-office procedures, including intravitreal anti-VEGF injections and retinal laser treatments.
Her training runs from SUNY Downstate to Harvard
Dr. Raparia is a Long Island native. She earned her undergraduate degree through the combined B.A./M.D. program between Macaulay Honors College at Brooklyn College and SUNY Downstate Medical Center. She received her medical degree from SUNY Downstate with a Distinction in Research and was selected for its Clinical Neurosciences Pathway Honors Program.
She completed her ophthalmology residency at SUNY Downstate, then a fellowship in Medical Retina at Massachusetts Eye and Ear Infirmary, Harvard Medical School. She has authored multiple peer-reviewed publications and presented her research at professional and academic meetings.
She returns to the community where she grew up
Dr. Raparia said that serving the community where she grew up makes the role especially meaningful. She plans to help local patients protect their sight through advanced treatments and the latest medical technology.
SightMD Co-Founder Jeffrey Martin, MD, said Dr. Raparia shares the group's commitment to providing "exceptional, compassionate eye care close to home."
Dr. Raparia is board certified in ophthalmology. She is a member of the American Academy of Ophthalmology and the American Society of Retina Specialists.
SightMD is recruiting more ophthalmology professionals
SightMD New York is seeking additional ophthalmology professionals to join its team. Practice owners interested in merging or selling can contact Chief Medical Officer Brad Kligman, MD.